CISA, FDA warn of new Illumina DNA device vulnerability

Several U.S. agencies warned this week about a vulnerability affecting software in devices used for DNA research that would allow hackers access to sensitive patient information. The Food and Drug Administration (FDA) and the company behind the devices — Illumina — said they have not received any reports indicating the vulnerability has been exploited. Illumina

access briefs cisa device devices dna exploited fda food food and drug administration hackers illumina industry information privacy reports research software technology the company vulnerability